Chimera Investment (FRA:4CR0) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:4CR0 Chimera Investment Corp FRA:4CR0
46 GF Score
Price €11.30
GF Value €11.41
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Chimera Investment Research & Development?

Chimera Investment FRA:4CR0 -0.88% 46 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:4CR0 with a GF Score™ of 46/100 and a GF Value™ of €11.41 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Chimera Investment's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Chimera Investment  (FRA:4CR0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Chimera Investment Research & Development Related Terms

Chimera Investment Research & Development Historical Data

* Premium members only.

The historical data trend for Chimera Investment's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chimera Investment Research & Development Chart

Chimera Investment Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Chimera Investment Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:4CR0
46GF Score
Chimera Investment Corp FRA:4CR0
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chimera Investment Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Chimera Investment (FRA:4CR0) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Chimera Investment and its competitors.
Is Chimera Investment's Research & Development too high?
Chimera Investment's current Research & Development is €0.0 Mil. Overall, Chimera Investment has a GF Score™ of 46/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chimera Investment's Research & Development compare to ABR and MFA?
Chimera Investment's Research & Development of €0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Chimera Investment and its competitors. Chimera Investment's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chimera Investment stock overvalued right now?
Based on GuruFocus' analysis, Chimera Investment (FRA:4CR0) is currently considered Fairly Valued. The stock's GF Value™ is €11.41, compared to a current price of €11.30 — trading 1% below its estimated fair value. The current Research & Development is €0.0 Mil. Chimera Investment's overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Chimera Investment (FRA:4CR0), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chimera Investment (FRA:4CR0) Overvalued in 2026?

Based on GuruFocus' analysis, Chimera Investment stock appears to be undervalued. The current stock price of €11.30 is trading 1% below its estimated GF Value™ of €11.41. GuruFocus considers Chimera Investment to be Fairly Valued.

Key valuation signals for FRA:4CR0:

  • Research & Development: €0.0 Mil
  • GF Value™: €11.41 vs. price of €11.30 (1% below fair value)
  • GF Score™: 46/100 with 5 warning signs

No single metric tells the full story. See the FRA:4CR0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chimera Investment Business Description

Industry Real EstateREITs
Address 630 Fifth Avenue, Suite 2400, New York, NY, USA, 10111
Chimera Investment Corporation is an internally managed REIT whose principal business objective is to provide attractive risk-adjusted returns and distributable income through investment performance linked to mortgage credit fundamentals. Through its mortgage lending, investment management, and advisory services platforms, the Company operates as a fully integrated mortgage business that originates, manages, and invests in a diversified range of mortgage assets. The Company invests, directly or indirectly, generally on a levered basis across a spectrum of mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, MSRs, business purpose and investor loans, including RTLs, and other real estate-related assets.
46GF Score

Get the complete analysis for FRA:4CR0

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.30
Price
€11.41
GF Value